Nobel laureate Honjo failed to declare 2.2 billion yen

Japanese Nobel Prize winner and Kyoto University professor Tasuku Honjo, seen in this photo taken on June 13, 2019, failed to declare 2.2 billion yen ($20.7 million) in patent royalties paid by Ono Pharmaceutical Co. over four years through 2018 for the anti-cancer drug Opdivo developed through his studies, which tax authorities recognized as taxable income, a source familiar with the matter said Sept. 10, 2020. Honjo filed a lawsuit in June 2020 against Ono Pharmaceutical over the royalty contract for the cancer drug, for which he received the Nobel Prize in medicine in 2018.

• Product Code
• ILEA000202480

• Registered date
• 2020/9/10 10:23:37

• Credit
• Kyodo / Kyodo News Images

• Media source
• 2020 Kyodo News

• Media size
• 564 × 796 pixel

• Resolution
• 240 dpi

• Deployment size
• 100.75(KB)*

• Special instruction

*File size when opened in Photoshop, etc.